A Phase I/II Open Label Individual Dose Titration Trial of the Human Corticotropin- Releasing Factor (hCRF), Corticorelin Acetate Injection (Xerecept), to Determine the Tolerability of Xerecept in a Pediatric Population

Trial Profile

A Phase I/II Open Label Individual Dose Titration Trial of the Human Corticotropin- Releasing Factor (hCRF), Corticorelin Acetate Injection (Xerecept), to Determine the Tolerability of Xerecept in a Pediatric Population

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 03 Aug 2013

At a glance

  • Drugs Corticorelin (Primary)
  • Indications Brain cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top